Cargando…
An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse
It is widely acknowledged that new regimens are urgently needed for the treatment of tuberculosis. The primary endpoint in the Phase III trials is a composite outcome of failure at the end of treatment or relapse after stopping treatment. Such trials are usually both long and expensive. Valid surrog...
Autores principales: | Phillips, Patrick P. J., Fielding, Katherine, Nunn, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648512/ https://www.ncbi.nlm.nih.gov/pubmed/23667677 http://dx.doi.org/10.1371/journal.pone.0063840 |
Ejemplares similares
-
The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011) -
The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005) -
Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993) -
Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022) -
Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)